A Phase I Clinical Trial Adding Autologous Hematopoietic Stem Cells to Chimeric Antigen Receptor T-cell Therapy in Patients with Relapsed or Refractory Hematologic Malignancies

Presenter Information

Bryanna C. Reinhardt, LSUHSC-NOFollow
Joshua Sasine
John P. Chute

Location

LSUHSC-Human Development Center

Document Type

Presentation

Start Date

10-11-2022 8:00 AM

Recommended Citation

Reinhardt, Bryanna C.; Sasine, Joshua; and Chute, John P., "A Phase I Clinical Trial Adding Autologous Hematopoietic Stem Cells to Chimeric Antigen Receptor T-cell Therapy in Patients with Relapsed or Refractory Hematologic Malignancies" (2022). Graduate Research Day. 23.
https://digitalscholar.lsuhsc.edu/grad_rs/2022grd/abstracts/23